<DOC>
	<DOCNO>NCT01394926</DOCNO>
	<brief_summary>The purpose study find optimal dose 3 different dose level - 0.15 mL , 0.5 mL 1.5 mL Optison assess presence disease carotid artery compare pre-contrast post-contrast ultrasound ( U/S ) dose group .</brief_summary>
	<brief_title>Dose-Finding , Feasibility Study Optison Contrast Enhanced U/S Detection Carotid Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>The subject great equal 18 year age . The subject highly suspect establish carotid artery disease . The subject undergone refer either unilateral bilateral intraarterial Xray carotid angiography determination subject management ( within 30 day U/S procedure ) . The subject nondiagnostic U/S carotids define institutional standard . The subject present clinically active , serious , lifethreatening disease , life expectancy le 1 month study participation may compromise management subject reason judgment investigator make subject unsuitable participation study . The subject history acute occlusion require medical intervention artery ( include aorta ) within 6 month consent . The subject know suspected hypersensitivity component Optison , blood , blood product , albumin . The subject right left , bidirectional transient right leave cardiac shunt .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>CE-U/S - Contrast-Enhanced U/S</keyword>
	<keyword>U/S - Ultrasound</keyword>
	<keyword>Assess effectiveness</keyword>
</DOC>